This inventor holds 2 USPTO granted patents. Top assignee: Utrecht University. Active years: 2008-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008-2010
Title: Ana Patricia Yatsuda: Innovator in Piroplasmid Vaccine Development
Introduction
Ana Patricia Yatsuda is a prominent inventor based in Utrecht, Netherlands. She has made significant contributions to the field of biotechnology, particularly in the development of vaccines. With a total of two patents to her name, Yatsuda is recognized for her innovative work in immunology.
Latest Patents
Yatsuda's latest patents focus on a Piroplasmid vaccine. The invention relates to a Piroplasmid protein or an immunogenic fragment of the protein, along with a nucleic acid encoding the Piroplasmid protein or immunogenic fragment. Additionally, the invention encompasses cDNA fragments, recombinant DNA molecules, and live recombinant carriers that include the nucleic acid. It also pertains to host cells that comprise these cDNA fragments and recombinant DNA molecules. Furthermore, the invention details vaccines that include a Piroplasmid protein or an immunogenic fragment, methods for preparing such vaccines, and the use of these proteins or fragments for vaccine purposes, as well as diagnostic tests.
Career Highlights
Ana Patricia Yatsuda is affiliated with Universiteit Utrecht Holding B.V., where she continues her research and development efforts. Her work has been instrumental in advancing the understanding and application of Piroplasmid proteins in vaccine development.
Collaborations
Yatsuda collaborates with notable colleagues, including Erik De Vries and Fasila Razzia Gaffar. These partnerships enhance her research capabilities and contribute to the innovative projects she undertakes.
Conclusion
Ana Patricia Yatsuda is a key figure in the field of vaccine development, particularly with her work on Piroplasmid vaccines. Her contributions are paving the way for advancements in immunology and biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile